| Date Filed | Type | Description |
| 04/03/2023 |
4
| van Dijken Eeuwijk Monique (Director) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Exercised 5,485 options to buy
@ $0 |
|
| 04/03/2023 |
4
| Temeng Kwaku (Director) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Granted 6,419 options to buy
@ $0
Exercised 5,485 options to buy
@ $0 |
|
| 04/03/2023 |
4
| Straughen Michael (Director) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Paid exercise price by delivering 2,524 shares
@ $22.05, valued at
$55.7k
Granted 6,419 options to buy
@ $0
Exercised 5,485 options to buy
@ $0 |
|
| 04/03/2023 |
4
| Murray Katherine (Director) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Granted 6,419 options to buy
@ $0
Exercised 5,485 options to buy
@ $0 |
|
| 04/03/2023 |
4
| Klingensmith Harvey Robert (Director) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Granted 6,419 options to buy
@ $0
Exercised 5,485 options to buy
@ $0 |
|
| 04/03/2023 |
4
| Carnes Martha Z. (Director) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Granted 6,419 options to buy
@ $0
Exercised 5,485 options to buy
@ $0 |
|
| 01/04/2023 |
4
| Gresham Gwendolyn (SVP) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Paid exercise price by delivering 4,722 shares
@ $20.27, valued at
$95.7k
Exercised 12,000 options to buy
@ $0 |
|
| 01/04/2023 |
4
| Hill Christopher Scott (SVP & CFO) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Paid exercise price by delivering 12,470 shares
@ $20.27, valued at
$252.8k
Exercised 31,688 options to buy
@ $0 |
|
| 01/04/2023 |
4
| Daniels Kevin (CAO & Treasurer) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Paid exercise price by delivering 2,361 shares
@ $20.27, valued at
$47.9k
Exercised 6,000 options to buy
@ $0 |
|
| 01/04/2023 |
4
| Bruno Lawrence (Chairman and CEO) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Paid exercise price by delivering 35,892 shares
@ $20.27, valued at
$727.5k
Exercised 91,212 options to buy
@ $0 |
|
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Tattoli Mark Damian (SVP, Gen Counsel & Secretary) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Paid exercise price by delivering 276 shares
@ $13.48, valued at
$3.7k
Exercised 700 options to buy
@ $0 |
|
| 08/02/2022 |
4
| Tattoli Mark Damian (SVP, Gen Counsel & Secretary) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Paid exercise price by delivering 112 shares
@ $18.02, valued at
$2k
Paid exercise price by delivering 54 shares
@ $18.02, valued at
$973.1
Exercised 250 options to buy
@ $0
Exercised 120 options to buy
@ $0 |
|
| 05/27/2022 |
3
| Murray Katherine (Director) has filed a Form 3 on CORE LABORATORIES N V |
| 05/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| van Dijken Eeuwijk Monique (Director) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Granted 5,485 options to buy
@ $0
Exercised 4,307 options to buy
@ $0 |
|
| 04/04/2022 |
4
| Temeng Kwaku (Director) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Granted 5,485 options to buy
@ $0
Exercised 4,307 options to buy
@ $0 |
|
| 04/04/2022 |
4
| Straughen Michael (Director) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Paid exercise price by delivering 1,982 shares
@ $32.43, valued at
$64.3k
Granted 5,485 options to buy
@ $0
Exercised 4,307 options to buy
@ $0 |
|
| 04/04/2022 |
4
| Klingensmith Harvey Robert (Director) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Granted 5,485 options to buy
@ $0
Exercised 4,307 options to buy
@ $0 |
|
| 04/04/2022 |
4
| Carnes Martha Z. (Director) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Granted 5,485 options to buy
@ $0
Exercised 4,307 options to buy
@ $0 |
|
| 04/04/2022 |
4
| Barnett Gregory Barry (Director) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Exercised 4,307 options to buy
@ $0 |
|
| 03/02/2022 |
4
| Tattoli Mark Damian (SVP, Gen Counsel & Secretary) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Paid exercise price by delivering 50 shares
@ $27.51, valued at
$1.4k
Exercised 110 options to buy
@ $0 |
|
| 03/02/2022 |
4
| Daniels Kevin (CAO & Treasurer) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Paid exercise price by delivering 54 shares
@ $27.51, valued at
$1.5k
Exercised 120 options to buy
@ $0 |
|
| 02/17/2022 |
4
| Daniels Kevin (CAO & Treasurer) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Granted 9,500 options to buy
@ $0 |
|
| 02/17/2022 |
4
| Tattoli Mark Damian (SVP, Gen Counsel & Secretary) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Granted 17,588 options to buy
@ $0 |
|
| 02/17/2022 |
4
| Schreffler Gwendolyn (SVP) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Granted 17,588 options to buy
@ $0 |
|
| 02/17/2022 |
4
| Hill Christopher Scott (SVP & CFO) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Granted 43,236 options to buy
@ $0 |
|
| 02/17/2022 |
4
| Bruno Lawrence (Chairman and CEO) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Granted 127,424 options to buy
@ $0 |
|
| 01/04/2022 |
4
| Hill Christopher Scott (SVP & CFO) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Paid exercise price by delivering 9,259 shares
@ $22.31, valued at
$206.6k
Exercised 23,529 options to buy
@ $0 |
|
| 01/04/2022 |
4
| Schreffler Gwendolyn (SVP) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Paid exercise price by delivering 1,850 shares
@ $22.31, valued at
$41.3k
Exercised 4,700 options to buy
@ $0 |
|
| 01/04/2022 |
4
| Daniels Kevin (CAO & Treasurer) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Paid exercise price by delivering 1,496 shares
@ $22.31, valued at
$33.4k
Exercised 3,800 options to buy
@ $0 |
|
| 01/04/2022 |
4
| Bruno Lawrence (Chairman and CEO) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Paid exercise price by delivering 18,193 shares
@ $22.31, valued at
$405.9k
Exercised 46,233 options to buy
@ $0 |
|
| 12/03/2021 |
4
| Daniels Kevin (CAO & Treasurer) has filed a Form 4 on CORE LABORATORIES N V|
Txns:
| Paid exercise price by delivering 56 shares
@ $22.41, valued at
$1.3k
Exercised 140 options to buy
@ $0 |
|
|